CGMP Deviations: Firm did not adequately investigate customer complaints.
Prescription Drugs
💊 Drugs • 12,141 recalls
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Failed dissolution specifications
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Desmopressin Acetate Tablets, 0.1 mg Tablets, Rx Only, Packed in 30 Tablet (3 x 10) Cartons. Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217. NDC: 68084-606-21.
American Health Packaging
Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
Failed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing.
Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation
CGMP Deviation: Poor container closure of the bulk storage container
HydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL
Qualitest Pharmaceuticals
Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable
Lack of assurance of sterility: Potential channel leaks near the threaded vial port.
Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing.
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.